|
|
||||||||
The Journal of Immunology, Vol 144, Issue 6 2211-2215, Copyright © 1990 by American Association of Immunologists
ARTICLES |
OM Martinez, RS Gibbons, MR Garovoy and FR Aronson
Cytokine Biology Laboratory, University of California, San Francisco 94143-0128.
Recent studies have shown that IL-4 can affect lymphocyte responses to IL-2. To evaluate the effects of IL-4 on T cell responses to physiologically relevant stimuli, we studied normal human T cells cultured with a low concentration of anti-CD3 mAb and IL-2 in the presence and absence of added IL-4. The addition of IL-4 to cultures of T cells stimulated with anti-CD3 mAb and IL-2 reduced the proliferative response by 49 to 59%. The inhibitory effect was observed in 3-, 5-, and 7-day cultures. Inhibition was dose-dependent with maximal inhibition at concentrations greater than or equal to 5 to 10 U/ml IL- 4. IL-4-mediated inhibition occurred early during the T cell response, inasmuch as addition of IL-4 after stimulation for 24 h did not result in significant inhibition. Phenotypic analyses of cells cultured in the presence of anti-CD3 mAb, IL-2, and IL-4 suggested that the mechanism of regulation by IL-4 involves the inhibition of IL-2R expression. The proportion of both CD4+ and CD8+ cells that expressed IL-2R in response to IL-2 was diminished in the presence of IL-4, although HLA-DR levels were unaffected. Soluble IL-2R was also reduced in supernatants of cultures stimulated with anti-CD3 mAb, IL-2, and IL-4 as compared to cultures stimulated with anti-CD3 mAb and IL-2. These findings indicate that when normal human T cells are stimulated in vitro in a manner that approximates a physiologic interaction with Ag in vivo, rIL-4 provides a potent inhibitory signal to IL-2 responsive cells that is likely mediated by IL-4-induced inhibition of IL-2R expression.
This article has been cited by other articles:
![]() |
S. Olver, P. Groves, K. Buttigieg, E. S. Morris, M. L. Janas, A. Kelso, and N. Kienzle Tumor-Derived Interleukin-4 Reduces Tumor Clearance and Deviates the Cytokine and Granzyme Profile of Tumor-Induced CD8+ T Cells Cancer Res., January 1, 2006; 66(1): 571 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Conticello, F. Pedini, A. Zeuner, M. Patti, M. Zerilli, G. Stassi, A. Messina, C. Peschle, and R. De Maria IL-4 Protects Tumor Cells from Anti-CD95 and Chemotherapeutic Agents via Up-Regulation of Antiapoptotic Proteins J. Immunol., May 1, 2004; 172(9): 5467 - 5477. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, T. Bardos, Q. Shao, J. Tschopp, K. Mikecz, T. T. Glant, and A. Finnegan IL-4 Potentiates Activated T Cell Apoptosis Via an IL-2-Dependent Mechanism J. Immunol., April 1, 2003; 170(7): 3495 - 3503. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Y. Yang, L. H. Wang, K. Mihalic, W. Xiao, T. Chen, P. Li, L. M. Wahl, and W. L. Farrar Interleukin (IL)-4 Indirectly Suppresses IL-2 Production by Human T Lymphocytes via Peroxisome Proliferator-activated Receptor gamma Activated by Macrophage-derived 12/15-Lipoxygenase Ligands J. Biol. Chem., February 1, 2002; 277(6): 3973 - 3978. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-R. Yu, R. A. Kirken, M. G. Malabarba, H. A. Young, and J. R. Ortaldo Differential Regulation of the Janus Kinase-STAT Pathway and Biologic Function of IL-13 in Primary Human NK and T Cells: A Comparative Study with IL-4 J. Immunol., July 1, 1998; 161(1): 218 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J C Crispin and J Alcocer-Varela Interleukin-2 and systemic lupus erythematosus--fifteen years later Lupus, May 1, 1998; 7(4): 214 - 222. [Abstract] [PDF] |
||||
![]() |
G Lombardi, S Sidhu, R Batchelor, and R Lechler Anergic T cells as suppressor cells in vitro Science, June 10, 1994; 264(5165): 1587 - 1589. [Abstract] [PDF] |
||||
![]() |
M Kondo, T Takeshita, N Ishii, M Nakamura, S Watanabe, K Arai, and K Sugamura Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4 Science, December 17, 1993; 262(5141): 1874 - 1877. [Abstract] [PDF] |
||||
![]() |
P Salgame, J. Abrams, C Clayberger, H Goldstein, J Convit, R. Modlin, and B. Bloom Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones Science, October 11, 1991; 254(5029): 279 - 282. [Abstract] [PDF] |
||||
![]() |
D. Eardley and M. Koshland Glycosylphosphatidylinositol: a candidate system for interleukin-2 signal transduction Science, January 4, 1991; 251(4989): 78 - 81. [Abstract] [PDF] |
||||
![]() |
A. Masuda, T. Matsuguchi, K. Yamaki, T. Hayakawa, M. Kubo, W. J. LaRochelle, and Y. Yoshikai Interleukin-15 Induces Rapid Tyrosine Phosphorylation of STAT6 and the Expression of Interleukin-4 in Mouse Mast Cells J. Biol. Chem., September 15, 2000; 275(38): 29331 - 29337. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |